INS and diabetes mellitus: For instance, in the setting of hypoglycemia, a common side effect of insulin and insulin secretagogues used in the treatment of patients with diabetes [28], the balance between positive and negative primers is acutely offset, resulting in an acutely decreased threshold for platelet activation [29].